Browse articles from EyeWorld.org related to the retina. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves new phaco system ➤ Next-generation canaloplasty device launch ➤ New Nd:YAG laser launch ➤ Researchers explore non-surgical option to address vision loss ➤ Non-invasive method to examine conjunctival goblet cells in vivo ➤ ASCRS news and events
➤ Phase 3 clinical trials complete for ‘superpotent’ corticosteroid ➤ New rapid, quantitative MMP-9 tear test ➤ First pediatric patient dosed with experimental gene-editing therapy for Leber congenital amaurosis ➤ Study: Comparison of NCX 470 to latanoprost for glaucoma ➤ Collaborations for inherited retinal diseases ➤ ASCRS news and events
➤ Topline data from Phase 3 trial of presbyopia-correcting drop ➤ FDA gives 510(K) approval to updated neuromodulation therapy for increased tear production ➤ Enrollment complete for Phase 3 trial of reproxalap ➤ DME trial to focus on underrepresented patient populations ➤ BLA submitted to FDA for wet AMD therapy ➤ Companies collaborate to further develop gene therapy for retinal disease ➤ ASCRS news and events
➤ Nerve growth factor being studied as a possible treatment for Sjogren’s-related dry eye ➤ Investigational RNA therapy doesn’t meet primary endpoint ➤ Phase 1 clinical trial for bioerodible, sustained anti-VEGF delivery ➤ Positive interim data for diabetic retinopathy treatment ➤ Positive results in trial for high-dose aflibercept ➤ Additional Phase 3 trial data for Beovu in DME ➤ ASCRS news and events
➤ Controversies in cataract and refractive surgery ➤ Hot topics in ophthalmology ➤ Ophthalmic Premier League ➤ Management of retinal vasculitis
➤ Discussion of same-day bilateral cataract surgery ➤ DMEK in complex eyes ➤ Do’s and Don’ts of corneal crosslinking for keratoconus ➤ Reconstruction of the ocular surface ➤ Late-breaking developments in retina ➤ Long-term follow-up with port delivery system of ranibizumab for AMD
➤ FDA approves first prescription eye drop for presbyopia treatment ➤ Primary endpoint reached in Phase 2 trial for dry eye disease drug ➤ New type of retinal nerve cell discovered ➤ Companies enter collaboration to develop an oral DME, wet AMD treatment ➤ iCare USA acquires remote patient-monitoring tech company ➤ ASCRS news and events
➤ FDA approves nasal spray for dry eye ➤ Survey: 70% of adults don’t plan on receiving an eye exam this year ➤ Positive results in Phase 3 study for Acanthamoeba keratitis treatment ➤ Research on first-in-class therapy for retinal degenerative disease ➤ ASCRS news and events
➤ Survey: Patient perspectives on presbyopia ➤ Study: Wearable visual field testing device correlates with standard testing, offers efficiency ➤ Endpoints not met in blepharitis drug trial ➤ Retinal cell protection observed in non-clinical model with investigational IOP-lowering drug ➤ Extension study of investigational wet AMD therapy shows reduction of injection burden ➤ 12-month safety data reported from Phase 3 bevacizumab trial ➤ ASCRS news and events
➤ Patient enrollment complete for Phase 2 trial of DED drug candidate ➤ New investigational drug candidates for cornea, glaucoma, and wet AMD ➤ IND filed for glaucoma drug candidate ➤ Collaboration for one-time treatment of several retinal conditions ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.